{"id":7177,"date":"2024-11-25T20:07:56","date_gmt":"2024-11-25T20:07:56","guid":{"rendered":"https:\/\/cdafound.org\/?page_id=7177"},"modified":"2026-01-23T19:28:24","modified_gmt":"2026-01-23T19:28:24","slug":"home-2024","status":"publish","type":"page","link":"https:\/\/cdaf.org\/fr\/home-2024\/","title":{"rendered":"Accueil \u2013 2024"},"content":{"rendered":"\n
\"\"<\/span>
\n
\n

Eliminating Preventable Diseases, Globally.<\/p>\n\n\n

We support high-impact decision-making through research, disease burden and economic impact modeling, developing implementable strategies, developing innovative financing, and knowledge sharing.<\/p>\n\n\n\n

Our team of epidemiologists, modelers, programmers, and decision analysts have collaborated with over 100 countries and territories. We actively engage with more than 650 national experts, including academics, economists, NGOs, ministries of health and finance, and key opinion leaders, to develop national strategies.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
<\/span>
\n
\n
\n
\"\"<\/figure>\n\n\n\n

Study<\/h3>\n\n\n\n

CDA Foundation (CDAF) is a non-profit organization that specializes in the study of complex and poorly-understood diseases in order to provide countries\/territories with the data and information to create and implement successful elimination strategies.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n

Model<\/h3>\n\n\n\n

The Polaris Observatory provides epidemiological data, modeling tools, training and decision analytics to support eliminating hepatitis B and C globally by 2030.<\/p>\n\n\n\n

\n
See the Dashboard<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n

Impact<\/h3>\n\n\n\n

The Relink program offers grants to identify and connect diagnosed but untreated individuals with hepatitis C (HCV) and hepatitis B (HBV) infections. By providing assistance in accessing care, the program demonstrates how countries with high rates of lost-to-follow-up individuals can achieve the World Health Organization\u2019s (WHO) 2030 viral hepatitis elimination goals.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n

CDAF’s history is marked by a series of innovative activities that have shaped the global Hepatitis elimination efforts.<\/h2>\n<\/div>\n\n\n\n
1.7 Billion<\/dt>

The number of people around the world who have access to free screening as result of our work.<\/p><\/dd><\/div>

32 Million<\/dt>

The number people who have access to free lab tests.<\/p><\/dd><\/div>

24 Million<\/dt>

The number of people who have access to free viral hepatitis treatment.<\/p><\/dd><\/div><\/dl>\n\n\n